Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania

NCT00513669 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Falciparum Malaria

Interventions

BIOLOGICAL: PEV 301& 302 in virosomes
BIOLOGICAL: Inflexal V (active comparator)

Sponsor

Swiss Tropical & Public Health Institute

Collaborators

[object Object]
[object Object]